These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 14981231)
1. Consensus development conference on antipsychotic drugs and obesity and diabetes. ; ; ; Obes Res; 2004 Feb; 12(2):362-8. PubMed ID: 14981231 [No Abstract] [Full Text] [Related]
2. Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions. Megna JL; Schwartz TL; Siddiqui UA; Herrera Rojas M Ann Clin Psychiatry; 2011 May; 23(2):131-40. PubMed ID: 21547274 [TBL] [Abstract][Full Text] [Related]
3. Scientific standards: critical comments on the pharmacoepidemiological study of second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia. Cohen D J Clin Psychopharmacol; 2008 Aug; 28(4):461-2; author reply 462-4. PubMed ID: 18626279 [No Abstract] [Full Text] [Related]
4. Metabolic effects of treatment with atypical antipsychotics. Kane JM; Barrett EJ; Casey DE; Correll CU; Gelenberg AJ; Klein S; Newcomer JW J Clin Psychiatry; 2004 Nov; 65(11):1447-55. PubMed ID: 15554755 [No Abstract] [Full Text] [Related]
5. [Diabetes in treatment with antipsychotic drugs: who is at risk]]. Deuschle M MMW Fortschr Med; 2005 Dec; 147(51-52):34. PubMed ID: 16402705 [No Abstract] [Full Text] [Related]
6. Obesity, diabetes and hypertension associated with antipsychotic use in remitted schizophrenia. Saddichha S; Vishnuvardhan G; Akhtar S Int J Risk Saf Med; 2011; 23(3):181-5. PubMed ID: 22020398 [TBL] [Abstract][Full Text] [Related]
7. Weight gain and glucose and lipid metabolism disturbances during antipsychotic medication: a review. Koponen H; Saari K; Savolainen M; Isohanni M Eur Arch Psychiatry Clin Neurosci; 2002 Dec; 252(6):294-8. PubMed ID: 12563538 [TBL] [Abstract][Full Text] [Related]
8. Antipsychotic agents and cardiometabolic morbidity in youth. Kruszewski SP; Paczynski RP Arch Pediatr Adolesc Med; 2009 Apr; 163(4):394-5; author reply 395. PubMed ID: 19349574 [No Abstract] [Full Text] [Related]
9. Atypical antipsychotic drugs, diabetes and ethnicity. Ananth J; Kolli S; Gunatilake S; Brown S Expert Opin Drug Saf; 2005 Nov; 4(6):1111-24. PubMed ID: 16255668 [TBL] [Abstract][Full Text] [Related]
10. Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement. Citrome L; Volavka J J Clin Psychiatry; 2005 Aug; 66(8):1073-4. PubMed ID: 16086627 [No Abstract] [Full Text] [Related]
11. [Metabolic risk during antipsychotic treatment in patients with schizophrenia]. Rzewuska M Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977 [TBL] [Abstract][Full Text] [Related]